✦ A new generation of exhaled nitric oxide detection based on phase change sensing technology ✦ Exhaled nitric oxide measurement is widely used in the diagnosis and monitoring of various respiratory diseases, with high early sensitivity ✦ A variety of measurement modes can be freely combined for testing ✦ Continuous animation guide prompts, allowing patients of all ages to easily understand the process and get a better measurement experience
Reslink
Fractional exhaled nitric oxide (FeNO) is produced by airway cells, and its concentration is highly correlated with the number of inflammatory cells, which can be used as a biomarker of airway inflammation. Exhaled nitric oxide concentrations can be detected through mouth breath test and nasal breath test. The measurement of exhaled nitric oxide is widely used in the diagnosis and monitoring of respiratory diseases.
Inflammatory factors and drugs affect the concentration of FeNO by acting on iNOS (nitric oxide synthase). The concentration increases during inflammation and decreases during anti-inflammatory process. Therefore, FeNO, as a biomarker of airway inflammation, is widely referred to in the diagnosis and monitoring of bronchial asthma, chronic cough, COPD, etc.
In 2003, the FeNO measurement technology was approved by the US FDA for clinical use; in 2005, the American Thoracic Society and the European Society of Respiratory Diseases published technical guidelines for FeNO detection. Subsequently, the American Thoracic Society clarified the clinical application value, application scope and detection methods of FeNO, and issued the FeNO clinical guidelines in 2011. In 2017, the European Society of Respiratory Diseases developed technical standards for exhaled biomarkers of lung disease, including FeNO. In 2020, China's guidelines for the prevention and treatment of bronchial asthma clarified that FeNO measurement can evaluate the level of airway inflammation and asthma control, and can predict and evaluate the response to inhaled hormone therapy.
Reslink adopts Novlead's new generation of electrochemical sensor system. The product features are as follows:
• Intelligent control of expiratory flow: young children, elderly people, and patients with difficulty in exhaling at a constant rate can also meet the quality control requirements, with a high detection success rate
• Anti-condensation design: intelligent temperature and humidity adjustment, accurate and stable measurement results, suitable for use in different environments
• Convenient carrying design: built-in battery, portable handle, magnetic chuck handle, easy to take, convenient for outpatient, inspection and other scenarios
• Built-in operating system: users can enter patient information without connecting to a computer; the system supports data statistics, query, and printing functions
• Smart UI design: built-in multiple animation-guided measurements, making flow rate control more intuitive
